Table 7 Predictors of intensive care unit stay during hospitalization

Age

1.01 (0.97–1.04)

0.69

Male gender

0.88 (0.32–2.43)

0.81

 Malignancy

1.06 (0.39–2.88)

0.91

 Liver cirrhosis

3.38 (1.02–11.22)

0.047

3.45 (0.79–14.99)

0.1

 Diabetes mellitus

3.50 (1.21–10.14)

0.021

3.72 (1.01–13.70)

0.048

Medication

 Proton-pump inhibitor use

1.39 (0.44–4.39)

0.57

 Immunosuppression

4.11 (1.27–13.37)

0.019

 C-reactive Protein

1.02 (0.97–1.07)

0.37

 WBC

1.03 (0.97–1.09)

0.29

 Bilirubin

1.06 (0.95–1.18)

0.29

 Creatinine

1.82 (0.87–3.82)

0.11

 INR

6.74 (0.67–67.24)

0.10

Cholangitis

1.64 (0.62–4.36)

0.32

MDRO

1.08 (0.36–3.29)

0.89

Mycotic coinfection

3.92 (1.33–11.55)

0.013

5.54 (1.46–21.06)

0.012

 Carbapenem based

4.37 (1.49–12.81)

0.007

3.73 (1.09–12.89)

0.037

 Glycopeptide based

3.35 (1.21–9.25)

0.019

 Tigecycline based

2.14 (0.43–10.58)

0.35

 Metronidazole based

0.42 (0.11–1.64)

0.21